LEADER 01696nam  22004693  450 
001 9911027076503321
005 20250904081900.0
010   $a1-394-27061-5
010   $a1-394-27060-7
035   $a(CKB)40470568900041
035   $a(MiAaPQ)EBC32275621
035   $a(Au-PeEL)EBL32275621
035   $a(OCoLC)1535404832
035   $a(EXLCZ)9940470568900041
100   $a20250904d2025      uy         0
101 0 $aeng
135   $aur|||||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 10$aTargeted Chemotherapy with Personalized Immunotherapy $eAn AI Approach
205   $a1st ed.
210  1$aNewark :$cJohn Wiley & Sons, Incorporated,$d2025.
210  4$dİ2025.
215   $a1 online resource (536 pages)
311 08$a1-394-27058-5 
330   $aTargeted Chemotherapy with Personalized Immunotherapy: An AI Approach is an essential guide for healthcare teams, offering groundbreaking insights into novel immunotherapies and personalized treatments to improve cancer patient care and quality of life.In the last 20 years, there have been significant leaps forward in the treatment of cancer.
606   $aMEDICAL / Immunology$2bisacsh
615  7$aMEDICAL / Immunology
676   $a615.58
700   $aKumar$b Abhishek$0977677
701   $aDas$b Prasenjit$01842056
701   $aRathore$b Pramod Singh$01833323
701   $aAhuja$b Sachin$01837067
701   $aSharma$b Chetan$01608326
801  0$bMiAaPQ
801  1$bMiAaPQ
801  2$bMiAaPQ
906   $aBOOK
912   $a9911027076503321
996   $aTargeted Chemotherapy with Personalized Immunotherapy$94436002
997   $aUNINA